Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 207252

Expand all

DOCETAXEL (DOCETAXEL)
20MG/ML (20MG/ML)
Marketing Status: Prescription

Active Ingredient: DOCETAXEL
Proprietary Name: DOCETAXEL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20MG/ML (20MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A207252
Product Number: 001
Approval Date: Aug 9, 2017
Applicant Holder Full Name: JIANGSU HENGRUI PHARMACEUTICALS CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

DOCETAXEL (DOCETAXEL)
80MG/4ML (20MG/ML)
Marketing Status: Prescription

Active Ingredient: DOCETAXEL
Proprietary Name: DOCETAXEL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 80MG/4ML (20MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A207252
Product Number: 002
Approval Date: Aug 9, 2017
Applicant Holder Full Name: JIANGSU HENGRUI PHARMACEUTICALS CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

DOCETAXEL (DOCETAXEL)
160MG/8ML (20MG/ML)
Marketing Status: Prescription

Active Ingredient: DOCETAXEL
Proprietary Name: DOCETAXEL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 160MG/8ML (20MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A207252
Product Number: 003
Approval Date: Aug 9, 2017
Applicant Holder Full Name: JIANGSU HENGRUI PHARMACEUTICALS CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information